AGP Picks
View all

Vanuatu Health Times
Provided by AGP

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 10, 2026

Krystal Biotech to Present at Upcoming Investor Conferences
Nov. 10, 2026

Krystal Biotech to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Spyre Therapeutics to Participate in Upcoming Investor Conferences
Nov. 10, 2026

Spyre Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Aradigm appoints Tim Wentworth to board of directors
Nov. 10, 2026

Aradigm appoints Tim Wentworth to board of directors

Indeterminate GlobeNewswire
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
Nov. 10, 2026

Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King

Indeterminate GlobeNewswire
Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London
Nov. 10, 2026

Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
Nov. 10, 2026

Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Survey Suggests a Simple Beverage Swap Can Inspire Healthier Habits Among Seniors
Nov. 10, 2026

Survey Suggests a Simple Beverage Swap Can Inspire Healthier Habits Among Seniors

Indeterminate GlobeNewswire
ALX Oncology to Present at Upcoming Investor Conferences
Nov. 10, 2026

ALX Oncology to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
Nov. 10, 2026

Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members

Indeterminate GlobeNewswire
MannKind to Participate in Upcoming Investor Conferences
Nov. 10, 2026

MannKind to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update
Nov. 10, 2026

Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases
Nov. 10, 2026

BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases

Indeterminate GlobeNewswire
Prolynx to Present Preclinical Data at ObesityWeek® 2026 Demonstrating the Potential for Quarterly Dosing with its Platform and Pipeline of Ultra-Long-Acting Anti-Obesity Peptides
Nov. 10, 2026

Prolynx to Present Preclinical Data at ObesityWeek® 2026 Demonstrating the Potential for Quarterly Dosing with its Platform and Pipeline of Ultra-Long-Acting Anti-Obesity Peptides

Indeterminate GlobeNewswire
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
Nov. 10, 2026

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Nasus Pharma Announces Abstracts Accepted for Presentation at ACAAI 2026
Nov. 10, 2026

Nasus Pharma Announces Abstracts Accepted for Presentation at ACAAI 2026

Indeterminate GlobeNewswire
Odyssey Therapeutics Announces Publication Highlighting Differentiated Therapeutic Potential of TNFR2 Agonism
Nov. 10, 2026

Odyssey Therapeutics Announces Publication Highlighting Differentiated Therapeutic Potential of TNFR2 Agonism

Indeterminate GlobeNewswire
Paragon Genomics and Intelliseq Partner to Accelerate High-Throughput Pharmacogenomic Profiling
Nov. 10, 2026

Paragon Genomics and Intelliseq Partner to Accelerate High-Throughput Pharmacogenomic Profiling

Indeterminate GlobeNewswire
AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates
Nov. 10, 2026

AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Spero Therapeutics Appoints William Ho, M.D., Ph.D., to its Board of Directors
Nov. 10, 2026

Spero Therapeutics Appoints William Ho, M.D., Ph.D., to its Board of Directors

Indeterminate GlobeNewswire
RESTEM Receives FDA Clearance of IND for Phase 1/2 Clinical Trial of Restem-X in Knee Osteoarthritis
Nov. 10, 2026

RESTEM Receives FDA Clearance of IND for Phase 1/2 Clinical Trial of Restem-X in Knee Osteoarthritis

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Vanuatu Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.